← Evidence map

ReviewFrontiers in oncology2025

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma.

Tengyun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40927522